Susquehanna Fundamental Investments LLC Makes New $1.62 Million Investment in agilon health, inc. (NYSE:AGL)

Susquehanna Fundamental Investments LLC acquired a new position in agilon health, inc. (NYSE:AGL - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 850,627 shares of the company's stock, valued at approximately $1,616,000. Susquehanna Fundamental Investments LLC owned about 0.21% of agilon health at the end of the most recent quarter.

Several other large investors have also modified their holdings of AGL. Price T Rowe Associates Inc. MD lifted its position in agilon health by 41.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 338,529 shares of the company's stock worth $644,000 after acquiring an additional 98,377 shares during the last quarter. Hsbc Holdings PLC increased its position in agilon health by 205.3% in the 4th quarter. Hsbc Holdings PLC now owns 132,952 shares of the company's stock worth $249,000 after buying an additional 89,407 shares during the period. MetLife Investment Management LLC lifted its holdings in shares of agilon health by 4.0% during the fourth quarter. MetLife Investment Management LLC now owns 174,551 shares of the company's stock worth $332,000 after buying an additional 6,762 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of agilon health by 25.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 255,914 shares of the company's stock valued at $486,000 after acquiring an additional 51,852 shares during the period. Finally, Capital International Investors increased its position in agilon health by 72.0% during the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company's stock worth $42,431,000 after acquiring an additional 9,346,295 shares during the period.

agilon health Price Performance

NYSE:AGL traded up $0.04 during mid-day trading on Tuesday, reaching $4.16. 664,264 shares of the company were exchanged, compared to its average volume of 4,841,308. agilon health, inc. has a 12 month low of $1.50 and a 12 month high of $7.73. The stock has a market cap of $1.72 billion, a PE ratio of -4.45 and a beta of 0.38. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The company has a fifty day moving average of $4.24 and a 200 day moving average of $3.17.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. Sanford C. Bernstein raised agilon health from a "market perform" rating to an "outperform" rating and lifted their target price for the stock from $3.30 to $8.50 in a research report on Tuesday, April 8th. Cowen reaffirmed a "hold" rating on shares of agilon health in a report on Tuesday, April 15th. Stifel Nicolaus upped their target price on shares of agilon health from $2.00 to $3.00 and gave the company a "hold" rating in a research note on Wednesday, February 26th. Citigroup upgraded shares of agilon health from a "neutral" rating to a "buy" rating and raised their price target for the stock from $3.25 to $5.00 in a research note on Friday, April 25th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of agilon health in a research note on Friday, March 21st. Two investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat.com, agilon health presently has a consensus rating of "Hold" and an average target price of $4.81.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.